View:
Download XLS
Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 18, 2020
Accession Number:
0001104659-20-104500
Submission Type:
POS AM
CIK:
0001541157
Company Name:
Akari Therapeutics Plc
File Number:
333-239923